SCHEMBL12954471

SCHEMBL12954471

Cc1cnn2c(NCCN)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 7/20 0.55
▸ CDK2 P24941 7/20 0.53
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ CCNA2 P20248 1/20 0.38
▸ CCNA1 P78396 1/20 0.38
▸ NPC1 O15118 4/20 0.37
▸ RAB9A P51151 4/20 0.37
▸ NPY1R P25929 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CTNNB1 P35222 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304619 0.89 GSK3B (0.55) GSK3BCDK2MEN1KMT2ANPC1
SCHEMBL13305020 0.87 GSK3B (0.55) GSK3BCDK2MEN1KMT2ANPC1
SCHEMBL13305640 0.87 CDK2 (0.54) GSK3BCDK2MEN1KMT2ANPC1
SCHEMBL12953603 0.87 CDK2 (0.70) GSK3BCDK2CCNA2CCNA1
SCHEMBL13304993 0.87 CDK2 (0.53) GSK3BCDK2MEN1KMT2ACCNA2
SCHEMBL14546042 0.85 GSK3B (0.51) GSK3BCDK2MEN1KMT2ANPC1
SCHEMBL13289158 0.85 CDK2 (0.63) GSK3BCDK2MEN1KMT2ACCNA2
SCHEMBL13305418 0.83 CDK2 (0.63) GSK3BCDK2MEN1KMT2ACCNA2
SCHEMBL13305297 0.83 CDK2 (0.77) GSK3BCDK2MEN1KMT2ANPC1
SCHEMBL13304831 0.81 CDK2 (0.58) GSK3BCDK2MEN1KMT2ACCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720882-B1 PYRAZOLOPYRIMIDINE-DERIVATIVES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORP (US) 2011-01-05 — — EP disclosed
Send feedback